Bruce Car
Chief Scientific Officer, Agios Pharmaceuticals.
Companies
- Biohaven PharmaceuticalsChief Scientific Officer Oct 5, 2022 to now1
- Agios PharmaceuticalsChief Scientific Officer Jan 8, 2020 to Mar 3, 20222
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Agios Pharmaceuticals AGIO16,752 shares3$575.6K at $34.36Feb 22, 2022
Biohaven Pharmaceuticals BHVN37,715 shares4$423.9K at $11.24Jan 7, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 5, 2026Shares withheld for tax 2,381 shares at $9.93 of Biohaven Pharmaceuticals4
- Jan 5, 2026Exercised options 4,750 shares of Biohaven Pharmaceuticals4
- Jan 5, 2025Shares withheld for tax 2,331 shares at $38.64 of Biohaven Pharmaceuticals5
- Jan 5, 2025Exercised options 4,750 shares of Biohaven Pharmaceuticals5
- Jun 17, 2024Bought 30,000 shares at $33.58 of Biohaven Pharmaceuticals6
- Feb 22, 2022Shares withheld for tax 2,041 shares at $29.08 of Agios Pharmaceuticals3
- Feb 18, 2022Exercised options 6,874 shares of Agios Pharmaceuticals3
- Feb 10, 2022Shares withheld for tax 1,073 shares at $31.43 of Agios Pharmaceuticals7
- Feb 10, 2022Exercised options 3,667 shares of Agios Pharmaceuticals7
- Jan 6, 2022Shares withheld for tax 1,205 shares at $32.58 of Agios Pharmaceuticals8
- Jan 6, 2022Exercised options 3,437 shares of Agios Pharmaceuticals8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Jan 7, 2025
- 6SEC EDGARForm 4 filed Jun 20, 2024
- 7SEC EDGARForm 4 filed Feb 14, 2022
- 8SEC EDGARForm 4 filed Jan 10, 2022